Target intelligence / Profile preview

Prosaposin (PSAP)

Target
PSAP
Molecular classification
Lysosomal protein, Precursor protein, Sphingolipid activator protein, Glycoprotein, Neurotrophic factor, Other
01

Overview

Prosaposin (PSAP) is a highly conserved secreted glycoprotein that serves as the precursor of four saposin proteins (A, B, C, and D), which are essential activators for various lysosomal hydrolases involved in sphingolipid degradation[1][2][3][4]. PSAP acts as a molecular hub integrating lipid metabolism, neuronal survival, neuroprotection, immune modulation, and metabolic regulation through its cleavage products. Deficiency or mutation in PSAP leads to impaired sphingolipid catabolism, causing lysosomal storage disorders such as Gaucher disease and metachromatic leukodystrophy, as well as dysfunctional neuronal signaling and increased risk of neurodegeneration[2][3]. PSAP and its saposin derivatives are also important for immune system function, as they facilitate the presentation of lipid antigens to invariant natural killer T cells and modulate macrophage responses[2]. As a neurotrophic factor, PSAP supports synaptic plasticity and neuronal health, partially via receptor-mediated signaling through GPR37 and GPR37L1[2]. Its complex biological actions make PSAP a potential target for therapeutic intervention and a biomarker for several metabolic, neurodegenerative, and neoplastic diseases[2][3].

Other names
Saposin-ASaposin-B-ValSaposin-BSaposin-CSaposin-DGLBASAP1CSActSAP-1SAP-2Proactivator polypeptideProtein ACerebroside sulfate activatorDispersinSphingolipid activator protein 1Sulfatide/GM1 activatorA1 activatorCo-beta-glucosidaseGlucosylceramidase activatorSphingolipid activator protein 2Component CProtein Cvariant Gaucher diseasevariant metachromatic leukodystrophysaposin-Asaposin-Bsaposin-Csaposin-Dprecursor of saposinsPARK24PSAPDSAP2prosaposinproactivator polypeptidesphingolipid activator protein-1sphingolipid activator protein-2
02

Mechanism of action

Activation of lysosomal hydrolases (via saposin derivatives); Regulation of ganglioside and sphingolipid metabolism; Modulation of signaling pathways (ERK, PI3K/Akt, SK); Neurotrophic/receptor-mediated signaling (through GPR37 and GPR37L1); Immune cell modulation (lipid antigen presentation to iNKT cells)

03

Biological functions

Sphingolipid metabolism and degradationLysosomal enzyme activationCell signalingNeuroprotection and neuronal survivalSynaptic plasticityImmune modulationCell proliferationAnti-apoptosisMaintenance of metabolic homeostasisLipid antigen presentation to immune cells
04

Disease associations

Neurodegenerative disease (including Parkinson’s disease, Alzheimer’s disease, Krabbe disease, metachromatic leukodystrophy, Gaucher disease)CancerCardiovascular disease (atherosclerosis)InflammationLysosomal storage disordersOther
05

Safety considerations

Loss-of-function or mutation-associated lysosomal storage diseaseNeurological dysfunction if deficientPotential off-target effects if modulating PSAP or saposin activity in therapeuticsDisrupted immune and metabolic homeostasis
06

Biomarkers

Variant Prosaposin (PSAP) or saposin deficiencies as biomarkers for Gaucher disease, metachromatic leukodystrophy, and other lysosomal storage diseasesPSAP levels or glycoprotein status as biomarkers in some cancers and neurodegenerative diseases

Beyond the preview

Go deeper on Prosaposin (PSAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prosaposin (PSAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call